Clear aqueous parenteral composition for treatment and prevention of vitamin D deficiency and insufficiency, comprises Vitamin D3 and surfactant, and optionally diethylene glycol monoethyl ether or glycofurol, and optionally excipients
2023-11-30
专利权人CADILA PHARM LTD (CDLA-C)
申请日期2023-11-30
专利号IN202321081307-A
成果简介NOVELTY - Clear aqueous parenteral composition comprises 300000-600000 IU/ml Vitamin D3 and 5-50 wt.% surfactant, and optionally less than 5 wt.% Transcutol(RTM: Diethylene glycol monoethyl ether) or less than 5 wt.% glycofurol, and optionally excipients. USE - Clear aqueous parenteral composition for treatment and prevention of vitamin D deficiency and insufficiency. No biological data given. ADVANTAGE - The composition provides a clear solution with desirable viscosity, and can be administered as a single dose without side effects associated with oil-based Vitamin D3 containing parenteral formulations. DETAILED DESCRIPTION - An INDEPENDENT CLAIM is included for a process for the preparation of a clear aqueous parenteral composition comprising: solubilizing vitamin D3 in a solvent system comprising alcohol or diethyl ether, Transcutol(RTM: Diethylene glycol monoethyl ether) or glycofurol; adding a surfactant; adding water; evaporating alcohol or diethyl ether; optionally, adding pharmaceutically acceptable excipients selected from chelating agent, antioxidant and buffer; and adding water to make up final volume.
IPC 分类号A61K-031/59 ; A61K-047/12 ; A61K-047/26 ; A61K-047/44 ; A61K-009/00
国家印度
专业领域医药卫生
语种英语
成果类型专利
文献类型科技成果
条目标识符http://119.78.100.226:8889/handle/3KE4DYBR/19119
专题中国科学院新疆生态与地理研究所
作者单位
CADILA PHARM LTD (CDLA-C)
推荐引用方式
GB/T 7714
KANOJIYA M,KHAN I A,KHAMAR B M. Clear aqueous parenteral composition for treatment and prevention of vitamin D deficiency and insufficiency, comprises Vitamin D3 and surfactant, and optionally diethylene glycol monoethyl ether or glycofurol, and optionally excipients. IN202321081307-A[P]. 2023.
条目包含的文件
条目无相关文件。
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。